Acurx Pharmaceuticals, Inc.
News
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Down 5.4% in August
Ticker Report Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP - Get Free Report) was the recipient of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling...\n more…
New to The Street Announces its Five Corporate Interviews, Airing Episode 591 on the Fox Business Network, Tonight Monday, August 26, 2024, at 10:30 PM PT
Globe Newswire New to The Street Announces its Five Corporate Interviews, Airing Episode 591 on the Fox Business Network, Tonight Monday, August 26, 2024, at 10:30 PM PT\n\n Episode 591: 1).Acurx...\n more…
ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference
PR Newswire ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment Conference ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global...\n more…
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Short Interest Update
Ticker Report Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP - Get Free Report) was the target of a large decrease in short interest in the month of July. As of July 31st, there was short interest totalling 464,300...\n more…
HC Wainwright Analysts Increase Earnings Estimates for Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP)
Ticker Report Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP - Free Report) - Investment analysts at HC Wainwright increased their Q3 2024 earnings per share (EPS) estimates for Acurx Pharmaceuticals in a report...\n more…
